You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pharmacogenomics

Showing 26 - 50 of 537
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Retrospective Pharmacogenomics Research of EGFR-TKIs,Gefitinib

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • +4 more
    • Guangzhou, Guangdong, China
      Cancer Center, Sun Yat-sen University
    Oct 25, 2022

    Pharmacist-led Interventions to Improve Medication Use

    Enrolling by invitation
    • Pharmacogenomics
    • Old Age
    • Behavioral Intervention
    • +2 more
    • Orlando, Florida
      Tabula Rasa HealthCare Precision Pharmacotherapy Research and De
    May 3, 2022

    Implementation ofPharmacist-led Pharmacogenomic Clinical Service

    Enrolling by invitation
    • Adverse Drug Event
    • +3 more
    • Pharmacogenomic Testing
    • Orlando, Florida
      Tabula Rasa HealthCare Precision Pharmacotherapy Research and De
    Jun 13, 2022

    Type 2 Diabetes Trial in Baltimore (Pioglitazone)

    Completed
    Has Results
    • Type 2 Diabetes
    • Baltimore, Maryland
      University of Maryland School of Medicine
    Apr 27, 2021

    Pharmacogenomics of Heparin-Induced Thrombocytopenia

    Recruiting
    • Heparin-induced Thrombocytopenia
    • Blood Draw
    • Tucson, Arizona
      Banner University Medical Center - Tucson
    Apr 26, 2021

    Pharmacogenomics Trial (Indapamide 1.5 MG SR)

    Not yet recruiting
    • Pharmacogenomics
    • Indapamide 1.5 MG SR
    • (no location specified)
    Mar 15, 2022

    Pharmacogenomics of Warfarin in Hispanics and Latinos

    Recruiting
    • Thrombosis
    • Hemorrhage
    • Mouthwash sample
    • Blood Draw
    • Tucson, Arizona
      Banner University Medical Center - Tucson
    Apr 26, 2021

    Preeclampsia Trial in Philadelphia (Aspirin 81Mg Non-enteric coated Tab)

    Active, not recruiting
    • Preeclampsia
    • Aspirin 81Mg Non-enteric coated Tab
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    Aug 15, 2022

    Heart Diseases, Coronary Disease, Coronary Artery Disease Trial in Lancaster (Clopidogrel, Aspirin)

    Enrolling by invitation
    • Heart Diseases
    • +9 more
    • Lancaster, Pennsylvania
      Amish Research Clinic
    Jan 24, 2022

    Obesity Trial in Changsha (Liraglutide, Liraglutide;metformin)

    Withdrawn
    • Obesity
    • Changsha, Hunan, China
      Xiangya Hospital of Central South University
    Apr 8, 2021

    Diabetes, Type 2 Trial (Canagliflozin)

    Enrolling by invitation
    • Diabetes Mellitus, Type 2
    • (no location specified)
    Dec 7, 2021

    Pharmacogenomics of Drug Safety in Multiple Sclerosis

    Recruiting
    • Multiple Sclerosis
      • Vancouver, British Columbia, Canada
      • +4 more
      May 13, 2021

      Pharmacogenomic Testing inProgram of All-inclusive Care for

      Enrolling by invitation
      • Pharmacogenomics
      • Polypharmacy
      • Pharmacogenomic Testing
      • Orlando, Florida
        Tabula Rasa HealthCare Precision Pharmacotherapy Research and De
      Dec 17, 2021

      MDD Trial in Nashville (Genecept Assay)

      Terminated
      Has Results
      • Major Depressive Disorder
      • Genecept Assay
      • Nashville, Tennessee
        Centerstone
      Aug 16, 2021

      Direct Oral AntiCoagulants and Ticagrelor Study II

      Not yet recruiting
      • Novel Oral Anticoagulants
      • +11 more
      • Detection of genotype and RNA profile in platelet and white blood cell
      • +2 more
      • Hefei, Anhui, China
      • +5 more
      Mar 1, 2023

      Platelet Aggregation Inhibitors, Coronary Heart Disease Trial in Lancaster (Clopidogrel, Aspirin)

      Completed
      Has Results
      • Platelet Aggregation Inhibitors
      • Coronary Heart Disease
      • Lancaster, Pennsylvania
        Amish Research Clinic
      Feb 22, 2022

      Arthroplasty, Replacement, Knee, Pain, Postoperative Trial in Cincinnati (Genetic Panel for Analgesics)

      Terminated
      • Arthroplasty, Replacement, Knee
      • Pain, Postoperative
      • Genetic Panel for Analgesics
      • Cincinnati, Ohio
        Good Samaritan Hospital
      Feb 24, 2021

      Acute Lymphoblastic Leukemia (ALL) in Partial Remission, Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid

      Recruiting
      • Acute Lymphoblastic Leukemia (ALL) in Partial Remission
      • +2 more
      • Riyadh, Saudi Arabia
        King Faisal Specialist Hospital & Research Center
      Apr 4, 2022

      Mood Disorders, Anxiety Disorders, Psychotic Disorders Trial in Worldwide (Personalised medication advice based on

      Not yet recruiting
      • Mood Disorders
      • +2 more
      • Personalised medication advice based on pharmacogenetic testing
      • Syracuse, New York
      • +8 more
      Jan 11, 2023

      Pharmacogenomics in Pulmonary Arterial Hypertension

      Withdrawn
      • Pulmonary Arterial Hypertension
      • +2 more
      • Pittsburgh, Pennsylvania
        Allegheny General Hospital
      Nov 29, 2021

      Postoperative Nausea Trial in Rochester (Granisetron, Ondansetron)

      Completed
      Has Results
      • Postoperative Nausea
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Oct 4, 2020

      Pharmacogenomics Testing in Directing Optimal Use of Supportive

      Recruiting
      • Anatomic Stage III Breast Cancer AJCC v8
      • +45 more
      • Biospecimen Collection
      • +3 more
      • Scottsdale, Arizona
        Mayo Clinic in Arizona
      Feb 3, 2022

      Susceptibility Genes for APAP Induced Drug Induced LIver Injury

      Recruiting
      • Acetaminophen
      • +3 more
      • genetic polymorphism
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital with Nanjing Medical University
      Jul 14, 2021

      Arthroplasty Complications Trial in Alexandria (Pharmacogenomics Testing)

      Unknown status
      • Arthroplasty Complications
      • Pharmacogenomics Testing
      • Alexandria, Virginia
        Anderson Orthopaedic Research Institute
      Feb 10, 2021

      Attention Deficit Disorders With Hyperactivity Trial in Hamilton, Mountainside, Toms River (Pharmacogenomics report)

      Terminated
      • Attention Deficit Disorders With Hyperactivity
      • Pharmacogenomics report
      • Hamilton, New Jersey
      • +2 more
      May 14, 2020